EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Analisis Monitoring Efek Samping Obat Antituberkolosis Pada Pasien Rawat Jalan Di Puskesmas Payung Sekaki Pekanbaru

Wahyu Margi Sidoretno, Linda Febriani, Nadya Putri Aulia Serawaidi

JOPS (Journal of Pharmacy and Science) · 31.12.2025 · 9 (1) · 95-101

DOI: 10.36341/jops.v9i1.7382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JOPS (Journal of Pharmacy and Science), online erschienen am 31.12.2025. Verfasst von Wahyu Margi Sidoretno und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB) is the second leading cause of death from infectious diseases worldwide according to the World Health Organization (WHO). Antituberculosis drugs (ATDs) are the cornerstone of TB management; however, adverse drug effects may influence patient medication adherence and ultimately affect treatment outcomes. This study employed a descriptive observational design with a time-series approach conducted at the Payung Sekaki Primary Health Center, Pekanbaru. Data were collected from pulmonary TB outpatients using an adverse drug effect questionnaire and a medication adherence evaluation form. Adverse effects and adherence levels were assessed during both the intensive and continuation phases of treatment. During the intensive phase, the most frequently reported adverse effects were nausea and vomiting, associated with rifampicin (64.29%), isoniazid (57.14%), pyrazinamide (50%), and ethambutol (57.14%). In the continuation phase, the predominant adverse effect was tea-colored urine, mainly related to rifampicin (52.63%). Medication adherence was high, with 92.86% adherence during the intensive phase and increasing to 100% during the continuation phase. Adverse effects of antituberculosis drugs varied between treatment phases. Despite the occurrence of adverse effects, patient adherence remained high, highlighting adherence as a key factor in the successful management of tuberculosis therapy.

Zitieren

APA

Sidoretno, W. M., Febriani, L., & Serawaidi, N. P. A. (2025). Analisis Monitoring Efek Samping Obat Antituberkolosis Pada Pasien Rawat Jalan Di Puskesmas Payung Sekaki Pekanbaru. JOPS (Journal of Pharmacy and Science), 9(1), 95-101. https://doi.org/10.36341/jops.v9i1.7382

Vancouver

Sidoretno WM, Febriani L, Serawaidi NPA. Analisis Monitoring Efek Samping Obat Antituberkolosis Pada Pasien Rawat Jalan Di Puskesmas Payung Sekaki Pekanbaru. JOPS (Journal of Pharmacy and Science). 2025;9(1):95-101. doi:10.36341/jops.v9i1.7382

BibTeX
@article{Sidoretno2025,
  author = {Sidoretno, Wahyu Margi and Febriani, Linda and Serawaidi, Nadya Putri Aulia},
  title = {Analisis Monitoring Efek Samping Obat Antituberkolosis Pada Pasien Rawat Jalan Di Puskesmas Payung Sekaki Pekanbaru},
  journal = {JOPS (Journal of Pharmacy and Science)},
  year = {2025},
  volume = {9},
  number = {1},
  pages = {95--101},
  doi = {10.36341/jops.v9i1.7382}
}
Kostenlos starten →